RT Journal Article
SR Electronic
A1 Butterman, Eric
T1 Tigecycline plus Standard Therapy is More Effective than Standard Therapy Alone for Treating Infections in Febrile Neutropenic Cancer Patients
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 12
SP 11
OP 12
DO 10.1177/155989771112006
UL http://mdc.sagepub.com/content/11/12/11.abstract
AB Tigecycline, first in a new class of glycylcyclines, in combination with piperacillin/tazobactam, is effective, safe, and well tolerated in high-risk febrile neutropenic oncohematologic patients. This combination therapy may aid in reducing the increase and extensive use of carbapenems, which have been associated with an increase in multidrug-resistant bacteria.